<div id="readability-page-1"><p><span>Lam Research (NASDAQ:LRCX - Get Free Report)</span> had its price target boosted by stock analysts at Cantor Fitzgerald  from $115.00 to $120.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an &#34;overweight&#34; rating on the semiconductor company's stock. Cantor Fitzgerald's price target points to a potential upside of 20.38% from the company's current price.</p><ul><li>4 Semiconductor Stocks Earning Fresh Wall Street Upgrades</li></ul><p>Other research analysts have also issued reports about the stock. The Goldman Sachs Group began coverage on shares of Lam Research in a report on Thursday, July 10th. They issued a &#34;buy&#34; rating and a $115.00 target price on the stock. Raymond James Financial upped their target price on shares of Lam Research from $90.00 to $110.00 and gave the company an &#34;outperform&#34; rating in a report on Thursday, July 31st. UBS Group upped their target price on shares of Lam Research from $95.00 to $120.00 and gave the company a &#34;buy&#34; rating in a report on Monday, July 21st. Barclays  set a $83.00 target price on shares of Lam Research and gave the company an &#34;equal weight&#34; rating in a report on Monday, July 28th. Finally, KeyCorp upped their target price on shares of Lam Research from $105.00 to $115.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, July 15th. Twenty research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $107.30.</p><p><b>Get Our Latest Report on LRCX</b></p><h2>Lam Research Price Performance</h2><ul><li>Congress Is Dumping These 5 Stocks—Should You Follow?</li></ul><p>Shares of NASDAQ LRCX opened at $99.6820 on Thursday. The firm has a market capitalization of $126.16 billion, a P/E ratio of 23.96, a PEG ratio of 1.30 and a beta of 1.65. Lam Research has a one year low of $56.32 and a one year high of $108.02. The company's fifty day moving average is $98.06 and its two-hundred day moving average is $84.32. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. </p><p>Lam Research (NASDAQ:LRCX - Get Free Report) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping the consensus estimate of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The company had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. During the same period in the previous year, the firm earned $1.03 EPS. The business's revenue was up 33.6% on a year-over-year basis.  Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Analysts forecast that  Lam Research will post 3.71 EPS for the current fiscal year. </p><h2>Hedge Funds Weigh In On Lam Research</h2><ul><li>Is the Floor in for Lam Research After Bullish Earnings?</li></ul><p>A number of institutional investors and hedge funds have recently bought and sold shares of LRCX. Smallwood Wealth Investment Management LLC bought a new position in  Lam Research during the first quarter worth $26,000.  IMG Wealth Management Inc. bought a new position in  Lam Research during the second quarter worth $26,000.  West Paces Advisors Inc. bought a new position in  Lam Research during the fourth quarter worth $27,000.  Mpwm Advisory Solutions LLC bought a new position in  Lam Research during the fourth quarter worth $27,000.  Finally, Howard Hughes Medical Institute bought a new position in  Lam Research during the second quarter worth $27,000. Hedge funds and other institutional investors own  84.61% of the company's stock. </p><h2>About Lam Research</h2> (Get Free Report)<p>Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Lam Research</li><li>3 Stocks to Consider Buying in October</li><li>Palantir is Selling Off, BigBear.ai Could Be Your Hedge</li><li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li><li>Ozempic Boom: Hims &amp; Eli Lilly Lead Healthcare Bets</li><li>Short Selling - The Pros and Cons </li><li>3 Energy Stocks That Could Rally If the Oil Bears Are Wrong </li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lam Research Right Now?</h2><p>Before you consider Lam Research, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LRCX

SOXL

<p>Cantor Fitzgerald has raised its price target for Lam Research (NASDAQ:LRCX) from $115.00 to $120.00, maintaining an "overweight" rating. This new target suggests a potential upside of 20.38% from the current price. Other analysts have also upgraded their ratings, with a consensus price target of $107.30. Lam Research reported strong earnings, exceeding estimates with a revenue of $5.17 billion and a net margin of 29.07%. The company is involved in semiconductor processing equipment manufacturing.</p>

Cantor Fitzgerald Increases Lam Research (NASDAQ:LRCX) Price Target to $120.00